doi: 10.2174/187221312802652839 26 OkayamaY
J.2006New technologies for assessing UDP-glucuronosyltransferase (UGT) metabolism in drug discovery and development.31(Spring 2006),7378,1740-6749 89
Ongoing Commitment: Optimal results typically require ongoing treatment, though protocols may be adjusted over time based on progress and goals
Interactions Glutathione may interact with some medications
Structural protein organization
Key liver function markers, including ALT, TBIL, and ALB, showed notable enhancements, with ALT levels decreasing from 348.96 U/L to 31.11 U/L in the observation group, compared to 347.90 U/L to 56.90 U/L in the control group